The American Journal of Surgery
Volume 196, Issue 6 , Pages 827-833 , December 2008

Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making

  • Weesam Alkhatib, M.D.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • ,
  • Casey Hertzenberg, M.D.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • ,
  • William Jewell, M.D.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • ,
  • Mazin F. Al-Kasspooles, M.D.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • ,
  • Ivan Damjanov, M.D., Ph.D.

      Affiliations

    • Department of Pathology, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • ,
  • Mark S. Cohen, M.D.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS 66160, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1-913-588-6568; fax: +1-913-588-4593

Received 28 April 2008 ,Revised 29 July 2008

References 

  1. Cancer Facts and Figures: Report on Leading Sites of New Cancer Cases and Deaths—2008 Estimates. American Cancer Society. 2008;www.cancer.org
  2. Thompson JF, Morton DL, Kroon BBR. In: Textbook of Melanoma. London: Martin Dunitz; 2004;p. 7–8
  3. Essner R. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma. Cancer Metastasis Rev. 2006;25:257–267
  4. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413–423
  5. The Melanoma Research Foundation. Melanoma Fact Sheet. Vol. 2007. Hillsborough, NJ: The Melanoma Research Foundation; 2007;
  6. Hochwald SN, Coit DG. Role of elective lymph node dissection in melanoma. Semin Surg Oncol. 1998;14:276–282
  7. Wagner JD, Gordon MS, Chuang TY, et al. Current therapy of cutaneous melanoma. Plast Reconstr Surg. 2000;105:1774–1800
  8. Fischer B, Fischer ER. Studies concerning the regional lymph node (II. Maintenance of immunity). Cancer. 1971;27:1001–1004
  9. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  10. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol. 2000;469–474
  11. National Cancer Comprehensive Network Practice Guidelines for Oncology. Melanoma Version 1. 2009;1–40www.nccn.org
  12. Vuylsteke RJ, Van Leeuwen PA, Statius Muller MG, et al. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol. 2003;21:1057–1065
  13. Koopal SA, Tiebosch A, Piers A, et al. Frozen section analysis of sentinel lymph modes in melanoma patients. Cancer. 2000;89:1720–1725
  14. Ariyan S, Ariyan C, Farber LR, et al. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J Am Coll Surg. 2004;198:924–932
  15. Tanis PJ, Boom P, Schraffordt Koops H, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol. 2001;8:222–226
  16. Scolyer RA, Thompson JF, McCarthy SW, et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg. 2005;201:821–823
  17. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655–1663
  18. Emery RE, Stevens JS, Nash RW, et al. Sentinel node staging of primary melanoma by the “10% rule”: pathology and clinical outcomes. Am J of Surg. 2007;193(5):618–622
  19. Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10:676–680
  20. Cochran AJ, Essner R, Rose DM, et al. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch Surg. 2000;385:252–260
  21. Gipponi M, Solari N, Lionetto R, et al. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol. 2005;31:1191–1197
  22. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma (A multicenter trial). Ann Surg. 1990;230:453–463
  23. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 162 stage I and II melanoma patients. J Clin Oncol. 1999;17:976–983
  24. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253–2260
  25. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134:381–387

PII: S0002-9610(08)00642-9

doi: 10.1016/j.amjsurg.2008.07.034

The American Journal of Surgery
Volume 196, Issue 6 , Pages 827-833 , December 2008

Article Tools